U-Medico Inc. and TFBS Bioscience, Inc. are pleased to announce that they have entered into a business alliance focused on quality analysis. Leveraging our advanced analytical expertise and TFBS Bioscience’s strength in viral clearance studies and biosafety testing, we will jointly provide GMP QC testing services for viral vectors to clients worldwide.
🔔TFBS Bioscience x U-Medico Strategic Alliance We are excited to announce our strategic partnership with U-Medico Inc. to jointly launch GMP QC testing services for viral vectors and CGT therapeutics across Japan, Taiwan, and the Asia-Pacific region. This collaboration combines: 🔹 U-Medico’s advanced analytical technologies – including Analytical Ultracentrifugation (AUC) and Mass Photometry for precise viral vector characterization. 🔹 TFBS Bioscience’s expertise in biology-based assays, biosafety testing, and GMP viral vector manufacturing. Together, we provide a one-stop QC solution that supports regulatory submissions in Japan PMDA, US FDA, and Taiwan TFDA, accelerating the development of innovative gene and cell therapies with enhanced safety and quality assurance. With this alliance, TFBS Bioscience and U-Medico aim to establish a center of excellence for QC testing in Asia, helping transformative therapies reach patients faster. 🔗 Learn more: https://lnkd.in/gBFnkwYY #U-Medico #TFBS #CellAndGeneTherapy #ViralVector #GMP #QualityControl #StrategicPartnership #Biotech #Japan #Taiwan
